D

Dr Corp Ltd
SZSE:301177

Watchlist Manager
Dr Corp Ltd
SZSE:301177
Watchlist
Price: 28.95 CNY 0.21%
Market Cap: 11.6B CNY

Dr Corp Ltd
Interest Income Expense

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Dr Corp Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
D
Dr Corp Ltd
SZSE:301177
Interest Income Expense
ÂĄ174.5m
CAGR 3-Years
47%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Shenzhou International Group Holdings Ltd
HKEX:2313
Interest Income Expense
ÂĄ891.1m
CAGR 3-Years
9%
CAGR 5-Years
21%
CAGR 10-Years
23%
ANTA Sports Products Ltd
HKEX:2020
Interest Income Expense
ÂĄ1.9B
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
26%
Li Ning Co Ltd
HKEX:2331
Interest Income Expense
ÂĄ362.4m
CAGR 3-Years
-12%
CAGR 5-Years
22%
CAGR 10-Years
N/A
L
Lao Feng Xiang Co Ltd
SSE:600612
Interest Income Expense
-ÂĄ159.7m
CAGR 3-Years
21%
CAGR 5-Years
9%
CAGR 10-Years
-2%
L
Laopu Gold Co Ltd
HKEX:6181
Interest Income Expense
-ÂĄ10.9m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dr Corp Ltd
Glance View

In the bustling world of digital transformation, Dr Corp Ltd. has carved out its niche as an innovative leader that specializes in providing advanced software solutions tailored for the healthcare industry. Born out of a vision to streamline medical processes, the company has grown to become a pivotal player in the intersection of technology and medicine. At its core, Dr Corp Ltd. focuses on developing cutting-edge electronic health record systems, telemedicine platforms, and data analytics tools that aim to enhance patient care, streamline operations, and reduce costs for healthcare providers. Their suite of solutions is designed to integrate seamlessly into existing hospital infrastructure, offering medical practitioners intuitive tools for better data management and patient interaction. The revenue model of Dr Corp Ltd. is as sophisticated as its technology, embracing both subscription-based and licensing fees that provide a steady stream of income. Healthcare establishments often subscribe to Dr Corp's flagship software, drawn by its flexibility and ability to scale according to organizational needs. The company also capitalizes on its consulting services, offering bespoke solutions that include training and support to optimize the use of its products. This dual-pronged approach ensures a diversified income stream, allowing Dr Corp Ltd. to continually invest in research and development, staying ahead of technological curves and adapting to the ever-evolving demands of the healthcare industry. As a result, the firm maintains its reputation not only as a service provider but as a crucial partner in healthcare innovations.

Intrinsic Value
17.41 CNY
Overvaluation 40%
Intrinsic Value
Price
D

See Also

What is Dr Corp Ltd's Interest Income Expense?
Interest Income Expense
174.5m CNY

Based on the financial report for Dec 31, 2024, Dr Corp Ltd's Interest Income Expense amounts to 174.5m CNY.

What is Dr Corp Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
74%

Over the last year, the Interest Income Expense growth was -20%. The average annual Interest Income Expense growth rates for Dr Corp Ltd have been 47% over the past three years , 74% over the past five years .

Back to Top